Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Neuroview Technology
AddedFeb 18, 2024
UpdatedJun 18, 2026
Neuroview Technology

Neuroview Technology

Angel

Neuroview Technology: A data-driven platform specializing in medical devices.

HQ
Englewood, NJ, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Neuroview Technology is a data-driven medical device company focused on improving neurological outcomes. Their technology platform combines real-time EEG monitoring of patients' neurological states with smartphone integration and cloud-based data sharing between patients and care teams. The company's vision is to provide enduring solutions that enhance quality of life, improve clinical management, and reduce the cost of patient care.

Neuroview Technology's approach leverages advanced data analytics to offer comprehensive neurological monitoring and management solutions. By integrating real-time data collection, mobile technology, and cloud-based information sharing, the company aims to revolutionize neurological care, potentially leading to more effective treatments and improved patient outcomes.

Neuroview Technology - Similar Companies

NeuroFieldz logo

NeuroFieldz

neurofieldz.com

Epic Neuro logo

Epic Neuro

BrainHealth logo

BrainHealth

Neuro42 logo

Neuro42

neuroFit logo

neuroFit

neurofit.tech

Novela Neurotech logo

Novela Neurotech

novelaneuro.com

NeuroVision Imaging logo

NeuroVision Imaging

neurovision.com

Neurava logo

Neurava

Nerbio logo

Nerbio

nerbio.com

Neurologic Solutions logo

Neurologic Solutions

Neurodyne logo

Neurodyne

neuromore logo

neuromore

neuromore.com

NeuroVice logo

NeuroVice

neurovicellc.com

Precision Neuroscopics logo

Precision Neuroscopics

PainQx logo

PainQx

painqx.com

Neuroview Technology - Quick Facts

Who are Neuroview Technology's competitors?

Companies similar to Neuroview Technology include NeuroFieldz, Epic Neuro, BrainHealth and Neuro42.

When was Neuroview Technology founded?

Neuroview Technology was founded in 2016.

Where is Neuroview Technology's headquarters located?

Neuroview Technology's headquarters is located in Englewood, NJ, US.

When was Neuroview Technology's last funding round?

Neuroview Technology's most recent funding round was for $250k (USD) in December 2023.

How much has Neuroview Technology raised to-date?

As of Dec 19, 2023, Neuroview Technology has raised a total of $554.5k (USD).

How many employees does Neuroview Technology have?

Neuroview Technology has 10 employees as of Feb 5, 2024.

Neuroview Technology - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • AI
  • Data
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified